{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:36:45Z","timestamp":1789774605408,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00277-024-05776-y","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T19:01:40Z","timestamp":1714417300000},"page":"3947-3954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Early predictor for differentiation syndrome in newly diagnosed acute promyelocytic leukaemia patients treated with single-agent arsenic trioxide"],"prefix":"10.1007","volume":"103","author":[{"given":"Yujuan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"issue":"2","key":"5776_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/bjh.16151","volume":"187","author":"M Stahl","year":"2019","unstructured":"Stahl M, Tallman MS (2019) Differentiation syndrome in acute promyelocytic leukaemia [J]. Br J Haematol 187(2):157\u2013162. https:\/\/doi.org\/10.1111\/bjh.16151","journal-title":"Br J Haematol"},{"issue":"4","key":"5776_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7326\/0003-4819-117-4-292","volume":"117","author":"SR Frankel","year":"1992","unstructured":"Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell RP Jr. (1992) The \u201cretinoic acid syndrome\u201d in acute promyelocytic leukaemia [J]. Ann Intern Med 117(4):292\u2013296. https:\/\/doi.org\/10.7326\/0003-4819-117-4-292","journal-title":"Ann Intern Med"},{"issue":"15","key":"5776_CR3","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/nejm199710093371501","volume":"337","author":"MS Tallman","year":"1997","unstructured":"Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH (1997) All-trans-retinoic acid in acute promyelocytic leukaemia [J]. N Engl J Med 337(15):1021\u20131028. https:\/\/doi.org\/10.1056\/nejm199710093371501","journal-title":"N Engl J Med"},{"issue":"4","key":"5776_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1179\/102453309x12583347114176","volume":"15","author":"R Jeddi","year":"2010","unstructured":"Jeddi R, Gh\u00e9dira H, Menif S, Ben Neji H, Ben Amor R, Kacem K, Aissaoui L, Boutera\u00e2 W, Abdennebi Y, Raihane BL, Gouider E, Raouf H, H\u00e8la BA, Saad A, Zaher B, Meddeb B (2010) Treatment of acute promyelocytic leukaemia with PETHEMA LPA 99 protocol: a Tunisian single centre experience [J]. Haematology 15(4):204\u2013209. https:\/\/doi.org\/10.1179\/102453309x12583347114176","journal-title":"Haematology"},{"issue":"7","key":"5776_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.leukres.2013.04.011","volume":"37","author":"H Leblebjian","year":"2013","unstructured":"Leblebjian H, DeAngelo DJ, Skirvin JA, Stone RM, Wadleigh M, Werner L, Neuberg DS, Bartel S, McDonnell AM (2013) Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukaemia [J]. Leuk Res 37(7):747\u2013751. https:\/\/doi.org\/10.1016\/j.leukres.2013.04.011","journal-title":"Leuk Res"},{"issue":"11","key":"5776_CR6","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1016\/S0950-3536(05)80122-2","volume":"84","author":"L Vahdat","year":"1994","unstructured":"Vahdat L, Maslak P, Miller WH Jr., Eardley A, Heller G, Scheinberg DA, Warrell RP Jr. (1994) Early mortality and the retinoic acid syndrome in acute promyelocytic leukaemia: impact of leukocytosis, low-dose chemotherapy, PMN\/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid [J]. Blood 84(11):3843\u20133849. https:\/\/doi.org\/10.1016\/S0950-3536(05)80122-2","journal-title":"Blood"},{"issue":"1","key":"5776_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S1083-8791(00)70031-0","volume":"95","author":"MS Tallman","year":"2000","unstructured":"Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Rowe JM, Fran\u00e7ois C, Larson RS, Wiernik PH (2000) Clinical description of 44 patients with acute promyelocytic leukaemia who developed the retinoic acid syndrome [J]. Blood 95(1):90\u201395. https:\/\/doi.org\/10.1016\/S1083-8791(00)70031-0","journal-title":"Blood"},{"issue":"9","key":"5776_CR8","first-page":"3015","volume":"94","author":"MA Sanz","year":"1999","unstructured":"Sanz MA, Mart\u00edn G, Ray\u00f3n C, Esteve J, Gonz\u00e1lez M, D\u00edaz-Mediavilla J, Bolufer P, Barrag\u00e1n E, Terol MJ, Gonz\u00e1lez JD, Colomer D, Chill\u00f3n C, Rivas C, G\u00f3mez T, Ribera JM, Bornstein R, Rom\u00e1n J, Calasanz MJ, Arias J, Alvarez C, Ramos F, Deb\u00e9n G (1999) A modified AIDA protocol with anthracycline-based consolidation results in high antileukaemic efficacy and reduced toxicity in newly diagnosed PML\/RARalpha-positive acute promyelocytic leukaemia. PETHEMA group [J]. Blood 94(9):3015\u20133021","journal-title":"Blood"},{"issue":"1","key":"5776_CR9","doi-asserted-by":"publisher","first-page":"11935","DOI":"10.1038\/s41598-019-47937-4","volume":"9","author":"JH Yoon","year":"2019","unstructured":"Yoon JH, Kim HJ, Min GJ, Park SS, Jeon YW, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Lee JW (2019) Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukaemia [J]. Sci Rep 9(1):11935. https:\/\/doi.org\/10.1038\/s41598-019-47937-4","journal-title":"Sci Rep"},{"issue":"2","key":"5776_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/sj.leu.2402807","volume":"17","author":"S de Botton","year":"2003","unstructured":"de Botton S, Chevret S, Coiteux V, Dombret H, Sanz M, San Miguel J, Caillot D, Vekhoff A, Gardembas M, Stamatoulas A, Conde E, Guerci A, Gardin C, Fey M, Cony Makhoul D, Reman O, de la Serna J, Lefrere F, Chomienne C, Degos L, Fenaux P (2003) Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukaemia (APL) with low white blood cell counts: results from APL 93 trial [J]. Leukaemia 17(2):339\u2013342. https:\/\/doi.org\/10.1038\/sj.leu.2402807","journal-title":"Leukaemia"},{"issue":"11","key":"5776_CR11","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1182\/blood-2012-08-449918","volume":"121","author":"EM Rego","year":"2013","unstructured":"Rego EM, Kim HT, Ruiz-Arg\u00fcelles GJ, Undurraga MS, UriarteMdel R, Jacomo RH, Guti\u00e9rrez-Aguirre H, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, ChauffailleMde L, Chiattone CS, Martinez L, Meill\u00f3n LA, G\u00f3mez-Almaguer D, Kwaan HC, Garc\u00e9s-Eisele J, Gallagher R, Niemeyer CM, Schrier SL, Tallman M, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, L\u00f6wenberg B, Sanz MA (2013) Improving acute promyelocytic leukaemia (APL) outcome in developing countries through networking, results of the International Consortium on APL [J]. Blood 121(11):1935\u20131943. https:\/\/doi.org\/10.1182\/blood-2012-08-449918","journal-title":"Blood"},{"issue":"12","key":"5776_CR12","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1016\/j.leukres.2010.07.027","volume":"34","author":"S Serefhanoglu","year":"2010","unstructured":"Serefhanoglu S, Buyukasik Y, Goker H, Sayinalp N, Haznedaroglu IC, Aksu S, Ozcebe OI, Turgut M, Aslan R, Ozdemir E (2010) Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukaemia who received ATRA and anthracyclines (PETHEMA protocol) therapy [J]. Leuk Res 34(12):e317-319. https:\/\/doi.org\/10.1016\/j.leukres.2010.07.027","journal-title":"Leuk Res"},{"issue":"2","key":"5776_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.clml.2019.09.616","volume":"20","author":"M Sobas","year":"2020","unstructured":"Sobas M, Czy\u017c A, Montesinos P, Armatys A, Helbig G, Ho\u0142owiecka A, Pluta A, Zarzycka E, Pi\u0105tkowska-Jakubas B, Majcherek M, Lewandowski K, Go\u0142os A, Paluszewska M, Podhorecka M, Oleksiuk J, Skr\u0119t A, Hawrylecka D, Guzicka-Kazimierczak RE, W\u0105tek M, Gromek T, Charli\u0144ski G, Grosicki S, Holojda J, Mi\u015bkiewicz W, Martinez-Cuadr\u00f3n D, Sanz MA, Wr\u00f3bel T, Wierzbowska A, Giebel S (2020) Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukaemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukaemia Group (PALG) Experience [J]. Clin Lymphoma Myeloma Leuk 20(2):105\u2013113. https:\/\/doi.org\/10.1016\/j.clml.2019.09.616","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"5776_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.leukres.2017.09.006","volume":"61","author":"F Wang","year":"2017","unstructured":"Wang F, Jia JS, Wang J, Zhao T, Jiang Q, Jiang H, Zhu HH (2017) The kinetics of white blood cell and the predictive factors of leukocytosis under oral or intravenous arsenic as the first-line treatment for acute promyelocytic leukaemia [J]. Leuk Res 61:84\u201388. https:\/\/doi.org\/10.1016\/j.leukres.2017.09.006","journal-title":"Leuk Res"},{"issue":"4","key":"5776_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1182\/blood-2008-07-168617","volume":"113","author":"P Montesinos","year":"2009","unstructured":"Montesinos P, Bergua JM, Vellenga E, Ray\u00f3n C, Parody R, de la Serna J, Le\u00f3n A, Esteve J, Milone G, Deb\u00e9n G, Rivas C, Gonz\u00e1lez M, Tormo M, D\u00edaz-Mediavilla J, Gonz\u00e1lez JD, Negri S, Amutio E, Brunet S, Lowenberg B, Sanz MA (2009) Differentiation syndrome in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors [J]. Blood 113(4):775\u2013783. https:\/\/doi.org\/10.1182\/blood-2008-07-168617","journal-title":"Blood"},{"issue":"8","key":"5776_CR16","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1006\/bcmd.1998.0212","volume":"92","author":"S De Botton","year":"1998","unstructured":"De Botton S, Dombret H, Sanz M, Miguel JS, Caillot D, Zittoun R, Gardembas M, Stamatoulas A, Cond\u00e9 E, Guerci A, Gardin C, Geiser K, Makhoul DC, Reman O, de la Serna J, Lefrere F, Chomienne C, Chastang C, Degos L, Fenaux P (1998) Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukaemia The European APL Group [J]. Blood 92(8):2712\u20132718. https:\/\/doi.org\/10.1006\/bcmd.1998.0212","journal-title":"Blood"},{"issue":"4","key":"5776_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1365-2710.2008.00935.x","volume":"33","author":"E Patatanian","year":"2008","unstructured":"Patatanian E, Thompson DF (2008) Retinoic acid syndrome: a review [J]. J Clin Pharm Ther 33(4):331\u2013338. https:\/\/doi.org\/10.1111\/j.1365-2710.2008.00935.x","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"5776_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3892\/mco.2021.2274","volume":"14","author":"J Wen","year":"2021","unstructured":"Wen J, Xu F, Zhou Q, Hu H, Liu Y, Su J, Zhang Y, Qu W, Shi L (2021) Dynamic changes and multiplication rate of white blood cell count may direct the timing of cytoreduction chemotherapy during induction treatment in newly diagnosed acute promyelocytic leukaemia with low-intermediate risk [J]. Mol Clin Oncol 14(6):112. https:\/\/doi.org\/10.3892\/mco.2021.2274","journal-title":"Mol Clin Oncol"},{"issue":"6","key":"5776_CR19","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1046\/j.1537-2995.1991.31892023514.x","volume":"78","author":"ZX Chen","year":"1991","unstructured":"Chen ZX, Xue YQ, Zhang R, Tao RF, Xia XM, Li C, Wang W, Zu WY, Yao XZ, Ling BJ (1991) A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukaemia patients [J]. Blood 78(6):1413\u20131419. https:\/\/doi.org\/10.1046\/j.1537-2995.1991.31892023514.x","journal-title":"Blood"},{"issue":"9","key":"5776_CR20","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.exphem.2005.06.025","volume":"90","author":"J Zhou","year":"2005","unstructured":"Zhou J, Meng R, Sui X, Meng L, Jia J, Yang B (2005) Effects of administration styles of arsenic trioxide on intracellular arsenic concentration, cell differentiation and apoptosis [J]. Haematologica 90(9):1277\u20131279. https:\/\/doi.org\/10.1016\/j.exphem.2005.06.025","journal-title":"Haematologica"},{"issue":"15","key":"5776_CR21","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","volume":"133","author":"MA Sanz","year":"2019","unstructured":"Sanz MA, Fenaux P, Tallman MS, Estey EH, L\u00f6wenberg B, Naoe T, Lengfelder E, D\u00f6hner H, Burnett AK, Chen SJ, Mathews V, Iland H, Rego E, Kantarjian H, Ad\u00e8s L, Avvisati G, Montesinos P, Platzbecker U, Ravandi F, Russell NH, Lo-Coco F (2019) Management of acute promyelocytic leukaemia: updated recommendations from an expert panel of the European LeukaemiaNet [J]. Blood 133(15):1630\u20131643. https:\/\/doi.org\/10.1182\/blood-2019-01-894980","journal-title":"Blood"},{"issue":"4","key":"5776_CR22","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1182\/blood-2003-07-2462","volume":"103","author":"MA Sanz","year":"2004","unstructured":"Sanz MA, Mart\u00edn G, Gonz\u00e1lez M, Le\u00f3n A, Ray\u00f3n C, Rivas C, Colomer D, Amutio E, Capote FJ, Milone GA, De La Serna J, Rom\u00e1n J, Barrag\u00e1n E, Bergua J, Escoda L, Parody R, Negri S, Calasanz MJ, Bolufer P (2004) Risk-adapted treatment of acute promyelocytic leukaemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicentre study by the PETHEMA group [J]. Blood 103(4):1237\u20131243. https:\/\/doi.org\/10.1182\/blood-2003-07-2462","journal-title":"Blood"},{"key":"5776_CR23","doi-asserted-by":"publisher","first-page":"666182","DOI":"10.3389\/fpsyg.2021.666182","volume":"12","author":"R Bono","year":"2021","unstructured":"Bono R, Alarc\u00f3n R, Blanca MJ (2021) Report Quality of Generalized Linear Mixed Models in Psychology: A Systematic Review [J]. Front Psychol 12:666182. https:\/\/doi.org\/10.3389\/fpsyg.2021.666182","journal-title":"Front Psychol"},{"issue":"16","key":"5776_CR24","doi-asserted-by":"publisher","first-page":"27314","DOI":"10.18632\/oncotarget.15432","volume":"8","author":"L Tang","year":"2017","unstructured":"Tang L, Chai W, Ye F, Yu Y, Cao L, Yang M, Xie M, Yang L (2017) HMGB1 promotes differentiation syndrome by inducing hyperinflammation via MEK\/ERK signalling in acute promyelocytic leukaemia cells [J]. Oncotarget 8(16):27314\u201327327. https:\/\/doi.org\/10.18632\/oncotarget.15432","journal-title":"Oncotarget"},{"issue":"6","key":"5776_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cellimm.2007.01.008","volume":"3","author":"KH Bi","year":"2006","unstructured":"Bi KH, Jiang GS (2006) Relationship between cytokines and leukocytosis in patients with APL induced by all-trans retinoic acid or arsenic trioxide [J]. Cell Mol Immunol 3(6):421\u2013427. https:\/\/doi.org\/10.1016\/j.cellimm.2007.01.008","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"5776_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/PL00008489","volume":"21","author":"B Jin","year":"2006","unstructured":"Jin B, Hou KZ, Liu YP, Yu P (2006) Leukocytosis and retinoic acid syndrome in patients with acute promyelocytic leukaemia treated with arsenic trioxide [J]. Chin Med Sci J 21(3):171\u2013174. https:\/\/doi.org\/10.1007\/PL00008489","journal-title":"Chin Med Sci J"},{"issue":"18","key":"5776_CR27","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1182\/blood-2013-10-512640","volume":"123","author":"MA Sanz","year":"2014","unstructured":"Sanz MA, Montesinos P (2014) How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukaemia [J]. Blood 123(18):2777\u20132782. https:\/\/doi.org\/10.1182\/blood-2013-10-512640","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05776-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05776-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05776-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T09:03:49Z","timestamp":1729933429000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05776-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["5776"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05776-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"20 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}